Air Canada (TSX:AC) Just Became Investable Again

Air Canada (TSX:AC) finally has a catalyst for its contrarian investors to get excited about, as they await a safe and effective coronavirus vaccine.

| More on:
Aircraft wing plane

Image source: Getty Images

Air Canada (TSX:AC) stock is stuck in limbo amid unprecedented uncertainties that have made the air travel industry untouchable through the eyes of many smart long-term investors, including the likes of Warren Buffett, who cut his losses with U.S. airline stocks earlier in the year.

The air travel stocks are among the most hated plays right now. Air Canada stock is still down around 70% from its pre-pandemic highs, but there are reasons to grow optimistic as some positive COVID-19 developments could be on the way. As I noted in a prior piece, the airlines, including Air Canada, could be given a sustained lift well before that safe and effective vaccine arrives thanks to rapid COVID test kits that could be in the airline’s hands within a matter of months.

Air Canada orders a big batch of rapid coronavirus test kits

Two weeks ago, Air Canada ordered a batch of 25,000 rapid coronavirus tests that reportedly produce results in a matter of minutes. If such test kits are successful, count me as unsurprised if Air Canada stock goes into rally mode after months of treading water in the mid-teens. While rapid-testing technologies should give airline investors something to be optimistic about as they await a vaccine, one should not expect faster testing to be the singular cure for Air Canada’s ailments.

In a normalized environment, Air Canada derives a considerable chunk of its revenues from international flights. Even with rapid-testing procedures in place, traveler behaviour is unlikely to bounce back anywhere close to 2019 levels until COVID is finally conquered. Moreover, travel restrictions could continue to weigh heavily on the Canadian airline’s top line for the duration of this pandemic.

That said, I think testing is a real positive development that can provide some relief for Air Canada’s business, and I don’t think the good news has been factored into the share price at this juncture. With rapid testing in place, domestic travel could be in a position to recover modestly over the coming quarters, even in the face of a worsening second wave of COVID cases.

The real reason to own Air Canada stock is for its earnings potential in 2022 and beyond. Rapid tests can provide the airlines with a bit of near-term relief that can improve the firm’s chances of making it through this crisis without a massive government bailout. Air Canada has a solid liquidity position, a now muted cash burn rate, and a minimal amount of debt coming due over the next year.

Foolish takeaway

If there’s an airline that can weather the hailstorm in the air travel industry, it’s Air Canada. The advent of rapid-testing kits, I believe, improves the airline’s chances of making it out of this pandemic alive and think shares are now more investable than they were a few months ago.

At the time of writing, Air Canada stock trades at 2.3 times book value. If you think the firm will still be standing once the pandemic ends, there could be a good amount of upside to be had from these depressed levels. For now, investors appear skeptical of rapid-testing technologies and seem to be rattled over COVID-hit stocks, as the second wave of COVID worsens.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

More on Coronavirus

Aircraft wing plane
Coronavirus

Air Canada (TSX:AC) Stock: Ready to Take Off?

While Air Canada is handling what it can control really well, there are many worsening macro headwinds that will likely…

Read more »

rail train
Coronavirus

Bull or Bear: Why Analysts Changed Their Tune on Aecon Stock

Analysts had been champing at the bit for the construction company, but the tides have turned.

Read more »

Biotech stocks
Coronavirus

Is Bellus Health Stock Still a Buy After 30% Earnings Jump?

The biotech continues to make progress on obtaining FDA approval for its chronic-cough therapy.

Read more »

grow dividends
Coronavirus

Goodfood Stock Likely to Double in 2022!

Goodfood (TSX:FOOD) stock has had a huge rise and fall in the last few years. But at $1.85 a share,…

Read more »

grow dividends
Coronavirus

Canfor Stock Pops 5% as Sales Climb 15% YOY

Canfor (TSX:CFP) stock remained positive about its future in the global lumber market after profits climb 15% year over year.

Read more »

edit Safety First illustration
Coronavirus

2 Crash-Proof TSX Stocks I’d Buy With $5,000

These two TSX stocks have proven they can handle this economic downturn and likely will continue to be safe far…

Read more »

TSX Today
Coronavirus

What to Watch on the TSX on Tuesday, April 26

Earnings continue to come out on the TSX today, including Air Canada (TSX:AC). Meanwhile, investors may want to continue watching…

Read more »

think thought consider
Coronavirus

Should Investors Buy Goodfood Stock Ahead of Earnings?

Goodfood (TSX:FOOD) stock dropped on Wednesday ahead of the company's earnings release. And it's unclear whether there will be anything…

Read more »